FDA Blood Pressure Med Recall—What to Know Right Now

The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...
BioSpace

FDA’s Tidmarsh Exits Amid ‘Personal Conduct’ Probe

George Tidmarsh, who helmed the FDA’s Center for Drug Evaluation and Research, resigned Sunday following a complaint by biopharma investor Kevin Tang, whose affiliated company, Aurinia Pharmaceuticals ...
Health Affairs

District Court: Restrictions On Mifepristone Illegal But Will Remain In Effect Pending FDA Reconsideration

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
STAT

Uniqure’s FDA submission for its Huntington’s disease therapy thrown into question

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

FDA Warns Against Fluoride Tablets for Young Children

MONDAY, Nov. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is moving to limit the use of ...

FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare an…

This novel therapy offers the first FDA-approved option to address the root cause of this ultra-rare condition, which causes ...
STAT

Lawsuit against top FDA drug regulator is packed with incendiary texts, emails

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

FDA Issues Safety Alert for Radiofrequency Microneedling

Discuss the benefits and risks of RF microneedling and all alternative skin procedures with a licensed healthcare provider.